You are here

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

https://doi.org/10.1136/jitc-2021-004479corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Martín-Otal C, Lasarte-Cia A, Serrano D, et al. Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells. J ImmunoTher Cancer 2022;10:e004479. doi: 10.1136/jitc-2021-004479

    The author affiliations and funding statement has been updated.

    The following affiliations have been added to Juan Roberto Rodriguez-Madoz, Jesús San Miguel, Felipe Prosper and Juan Jose Lasarte:

    Centro de Investigacion Biomedica en Red de Cancer (CIBERONC)

    Cancer Center Universidad de Navarra (CCUN)

    The below information has been added to the funding statement:

    ISCiii Retic Tercel RD16/011/0005 funded by ISCiii+Fondos FEDER, Red de Terapias Avanzadas TERAV (RD21/0017/0009) funded by ISCiii+Unión Europea – NextGenerationEU Plan de Recuperación Transformación y Resiliencia